Related Experiment Video
Updated: Jul 3, 2026

Selected Reaction Monitoring Mass Spectrometry for Absolute Protein Quantification
Published on: August 17, 2015
From Method-Defined Signals to Reference Measurement Procedures: Two Decades of Mass Spectrometry-Based ProGRP
Donatella Coradduzza1, Emanuela Azara2, Anna La Salvia3
1Department of Biomedical Sciences, University of Sassari, Viale San Pietro 43/B, 07100Sassari, Italy.
Pro-gastrin-releasing peptide (ProGRP) measurement in cancer is improving with mass spectrometry (MS). MS offers more accurate quantification than immunoassays, addressing challenges in biomarker comparability for neuroendocrine neoplasms.
Area of Science:
- Biomarker Discovery
- Quantitative Proteomics
- Measurement Science
Background:
- Pro-gastrin-releasing peptide (ProGRP) is a key biomarker for small cell lung cancer (SCLC) and neuroendocrine neoplasms (NENs).
- Current immunoassay methods face limitations due to low analyte concentrations, proteoform heterogeneity, and lack of comparability.
- Mass spectrometry (MS) offers a more precise approach for quantifying protein biomarkers, resolving isoforms and proteoforms.
Purpose of the Study:
- To review two decades of MS-based ProGRP quantification as a case study in clinical proteomics and measurement science.
- To highlight the evolution of MS techniques for improved selectivity and metrological robustness.
- To address the fundamental comparability issue between immunoassay and MS-based biomarker measurements.
Main Methods:
- Review of mass spectrometry (MS) workflows for ProGRP quantification over 20 years.
- Examination of advancements from single-quadrupole methods to isotope dilution strategies.
- Analysis of performance gains driven by selectivity engineering and internal standardization.
Main Results:
- MS-based methods have evolved towards greater selectivity and metrological robustness in ProGRP measurement.
- Performance improvements in MS were primarily due to selectivity and standardization, not mass analyzer advancements.
- A fundamental discordance exists between immunoassay and MS measurements, as they quantify different entities.
Conclusions:
- Harmonizing quantitative protein biomarker measurements requires a metrological framework, including defined measurands and reference measurement procedures (RMPs).
- Protein-level isotope dilution MS is crucial for establishing traceability and comparability.
- ProGRP serves as an important model for advancing quantitative protein biomarker analysis in clinical proteomics.
Related Concept Videos
Tandem Mass Spectrometry
Mass Spectrometry: Overview
Mass Spectrometry: Complex Analysis
GC–MS is a powerful hyphenated method commonly used in forensics and environmental...
Mass Spectrometers
Mass Analyzers: Overview
Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...

